Join today and have your say! It’s FREE!

We will not release or resell your information to third parties without your permission.

Please Try Again

{{ error }}

By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Please Try Again

{{ error }}

Password Hint : {{passwordHint}}

Remember me

Forgot Password?

or

Privacy Policy | Disclaimer

Quote | Bullboard | News | Opinion | Profile | Peers | Filings | Financials | Options | Price History | Ratios | Ownership | Insiders | Valuation

Bullboard - Stock Discussion Forum Agenus Inc AGEN

Healthcare Biotechnology

Agenus Inc. is an immuno-oncology (I-O) company targeting cancer and infectious diseases with a pipeline of immunological agents. It is specialized in developing therapies to activate the body's immune system against cancer and infections. Its pipeline includes immune-modulatory antibodies, adoptive cell therapies (via MiNK Therapeutics, Inc.), and vaccine adjuvants (via SaponiQx, Inc.). Its... see more

Add To Watchlist

Bullboard (NDAQ:AGEN)

View:

Post by PressReleaseon Oct 06, 2024 8:21am

New Press Release - Lost Money on Agenus Inc.(AGEN)? Join Class Action Suit Seeking Recovery - Contact Levi & Korsinsky

NEW YORK, NY / ACCESSWIRE / October 6, 2024 / If you suffered a loss on your Agenus Inc. (NASDAQ:AGEN) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:https://zlk.com/pslra-1/agenus-lawsuit-submission-form?prid...read article.

Post by PressReleaseon Oct 06, 2024 8:09am

New Press Release - ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Agenus

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Agenus To Contact Him Directly To Discuss Their OptionsIf you suffered losses exceeding $50,000 in Agenus between January 23, 2023 and July 17, 2024 and would like...read article.

Post by PressReleaseon Oct 06, 2024 7:02am

New Press Release - AGEN INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Agenus Inc. Shareholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!

NEW YORK CITY, NY / ACCESSWIRE / October 6, 2024 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Agenus Inc. ("Agenus" or "the Company") (NASDAQ:AGEN) and certain of its officers.Class DefinitionThis...read article.

Post by PressReleaseon Oct 05, 2024 11:02pm

New Press Release - Levi & Korsinsky Notifies Shareholders of Agenus Inc.(AGEN) of a Class Action Lawsuit and an Upcoming Deadline

NEW YORK, NY / ACCESSWIRE / October 5, 2024 / If you suffered a loss on your Agenus Inc. (NASDAQ:AGEN) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:https://zlk.com/pslra-1/agenus-lawsuit-submission-form?prid...read article.

Post by PressReleaseon Oct 05, 2024 9:02pm

New Press Release - Agenus Inc. Sued for Securities Law Violations - Contact Levi & Korsinsky Before November 5, 2024 to Discuss Your Rights - AGEN

NEW YORK, NY / ACCESSWIRE / October 5, 2024 / If you suffered a loss on your Agenus Inc. (NASDAQ:AGEN) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:https://zlk.com/pslra-1/agenus-lawsuit-submission-form?prid...read article.

Post by PressReleaseon Oct 05, 2024 12:02pm

New Press Release - SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Agenus Inc. of Class Action Lawsuit and Upcoming Deadlines - AGEN

NEW YORK, NY / ACCESSWIRE / October 5, 2024 / Pomerantz LLP announces that a class action lawsuit has been filed against Agenus Inc. ("Agenus" or the "Company") (NASDAQ:AGEN) and certain officers. The class action, filed in the United States District Court for the District of Massachusetts, and...read article.

Post by PressReleaseon Oct 05, 2024 11:01am

New Press Release - The Schall Law Firm Urges Investor Participation In A Case Against Agenus Inc. For Securities Related Infractions

LOS ANGELES, CA / ACCESSWIRE / October 5, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Agenus Inc. ("Agenus" or "the Company") (NASDAQ:AGEN) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934...read article.

Post by PressReleaseon Oct 05, 2024 9:02am

New Press Release - ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Agenus Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - AGEN

New York, New York--(Newsfile Corp. - October 5, 2024) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Agenus Inc. (NASDAQ: AGEN) between January 23, 2023 and July 17, 2024, both dates inclusive (the "Class Period"), of the important November 5, 2024...read article.

Post by PressReleaseon Oct 05, 2024 7:44am

New Press Release - INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Agenus

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Agenus To Contact Him Directly To Discuss Their OptionsNEW YORK, NY / ACCESSWIRE / October 5, 2024 / If you suffered losses exceeding $50,000 in Agenus between...read article.

Post by PressReleaseon Oct 04, 2024 11:03am

New Press Release - Agenus Inc Is Being Sued For Possible Securities Fraud And Affected Shareholders Are Encouraged To Help The Schall Law Firm

LOS ANGELES, CA / ACCESSWIRE / October 4, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Agenus Inc. ("Agenus" or "the Company") (NASDAQ:AGEN) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934...read article.

Post by PressReleaseon Oct 04, 2024 9:37am

New Press Release - ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Agenus Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - AGEN

New York, New York--(Newsfile Corp. - October 4, 2024) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Agenus Inc. (NASDAQ: AGEN) between January 23, 2023 and July 17, 2024, both dates inclusive (the "Class Period"), of the important November 5, 2024...read article.

Post by PressReleaseon Oct 03, 2024 7:00pm

New Press Release - AGEN Investors Have Opportunity to Lead Agenus Inc. Securities Fraud Lawsuit

NEW YORK, Oct. 3, 2024 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Agenus Inc. (NASDAQ: AGEN) between January 23, 2023 and July 17, 2024, both dates inclusive (the "Class Period"), of the important November 5, 2024 lead plaintiff deadline...read article.

Post by PressReleaseon Oct 03, 2024 5:36pm

New Press Release - DEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Agenus

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Agenus To Contact Him Directly To Discuss Their OptionsIf you suffered losses exceeding $50,000 in Agenus between January 23, 2023 and July 17, 2024 and would like...read article.

Post by PressReleaseon Oct 03, 2024 11:01am

New Press Release - The Schall Law Firm Urges Investor Participation In A Case Against Agenus Inc. For Securities Related Infractions

LOS ANGELES, CA / ACCESSWIRE / October 3, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Agenus Inc. ("Agenus" or "the Company") (NASDAQ:AGEN) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934...read article.

The Market Update

{{currentVideo.title}} {{currentVideo.relativeTime}}

< Previous bulletin

Next bulletin >

A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}

{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}

{{currentVideo.headline}}

{{currentVideo.link1Text}}

{{currentVideo.link2Text}}

< Previous

{{moreVideoText}}

Next >

Dealroom for high-potential pre-IPO opportunities